Video

Targeted Therapy in Metastatic Breast Cancer for Patients with BRCA Mutations

Author(s):

Martin Dietrich, MD, PhD,Ellen Ball, ANP-FNP

Key opinion leaders explain how early they introduce targeted therapy in mutated breast cancer.

Related Videos
5 KOLs are featured in this series.
5 KOLs are featured in this series.
Related Content
Erika P. Hamilton, MD
December 5th 2022

Antibody-Drug Conjugates Expand HER2+ Breast Cancer Treatment Options

Peter Gibbs, MBBS, MD, FRACP, a medical oncologist at St Vincent’s Private Hospitals and a professor at the University of Melbourne in Australia
December 5th 2022

MRD Detection Emerges as a Catalyst for Advances in Colon Cancer

DetermaIO Assay Helps Inform Benefit With Single-Agent Immunotherapy in Advanced NSCLC
November 22nd 2022

DetermaIO Assay Helps Inform Benefit With Single-Agent Immunotherapy in Advanced NSCLC

Shaji Kumar, MD
September 1st 2022

Biomarker-Directed Therapy in Multiple Myeloma Signals the Future of the Field

Treating Patients with Gastric Cancer
August 25th 2022

Treating Patients with Gastric Cancer

Multidisciplinary Management of Patients with Basal Cell Carcinoma
August 24th 2022

Multidisciplinary Management of Patients with Basal Cell Carcinoma